Well, Hy, you can go to countless other OTC stocks and see companies with promises of "deals coming down the pipe".
The key here is for Joe to keep putting together the actual deals and keep moving forward with the science. $2.6MM and $5MM up-front payments are huge for keeping us away from toxic financing.
And having these groups behind the development is a huge factor in increasing any possibilities of success there might be for the various items "in the hopper".
But until the world sees revenues and a functioning business (China Excellagen license/ramp up, AZ CCM project, vaccine testing success, etc.), this is our lot.
That said, it would only take one or two large investors or 50-100 folks who think they'd like to buy a few 100k shares each (not a huge investment under $1 for a significant amount of investors) to push us out of this 6-digits-behind-the-decimal trading purgatory.
Getting closer all the time. The fact that this wasn't the deal to push us over the top isn't the last word. Momentum is clearly building, and the chances we go under any time soon (which is how we are currently priced) are dwindling with every success.
Generex Biotechnology Corp. (GNBT) Stock Research Links